Nephro-Urology Monthly

Published by: Kowsar

Global Scientific Vision With Local Vigilance: Renal Transplantation in Developing Countries

Mohammad Reza Ardalan 1 , *
Author Information
1 Chronic Kidney Disease Research Center, Tabriz University of Medical Sciences, Tabriz, IR Iran
Article information
  • Nephro-Urology Monthly: January 01, 2015, 7 (1); e22653
  • Published Online: December 20, 2014
  • Article Type: Review Article
  • Received: August 9, 2014
  • Revised: August 30, 2014
  • Accepted: September 13, 2014
  • DOI: 10.5812/numonthly.22653

To Cite: Ardalan M R. Global Scientific Vision With Local Vigilance: Renal Transplantation in Developing Countries, Nephro-Urol Mon. 2015 ; 7(1):e22653. doi: 10.5812/numonthly.22653.

Copyright © 2014, Nephrology and Urology Research Center. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Context
2. Evidence Acquisitions
3. Results
4. Conclusions
  • 1. Ebpg Expert Group on Renal Transplantation . European best practice guidelines for renal transplantation. Section IV: Long-term management of the transplant recipient. Nephrol Dial Transplant. 2002; 17 Suppl 4: 1-67[PubMed]
  • 2. Jacob AA. Guillermo Garcia Garcia Paul Harden, Jeremy Chapman The Global Role of Kidney Transplantation. Nephrol Dial Transplant. 2012; 1(1)
  • 3. Gonzalez A, Schmitter K, Hirsch HH, Garzoni C, van Delden C, Boggian K, et al. KIR-associated protection from CMV replication requires pre-existing immunity: a prospective study in solid organ transplant recipients. Genes Immun. 2014; 15(7): 495-9[DOI][PubMed]
  • 4. Ardalan MR. Tabriz nephro-educational courses; A global scientific vision with local vigilance. J Ren Inj Prev. 2014; 3(1): 7-8
  • 5. Ortiz F, Gelpi R, Koskinen P, Manonelles A, Raisanen-Sokolowski A, Carrera M, et al. IgA nephropathy recurs early in the graft when assessed by protocol biopsy. Nephrol Dial Transplant. 2012; 27(6): 2553-8[DOI][PubMed]
  • 6. Ardalan MR, Nasri H. Anti-phospholipase A2 receptor antibody in idiopathic membranous nephropathy: New concepts. J Res Med Sci. 2013; 18(6): 459-61[PubMed]
  • 7. Stanescu HC, Arcos-Burgos M, Medlar A, Bockenhauer D, Kottgen A, Dragomirescu L, et al. Risk HLA-DQA1 and PLA(2)R1 alleles in idiopathic membranous nephropathy. N Engl J Med. 2011; 364(7): 616-26[DOI][PubMed]
  • 8. Ghafari A, Etemadi J, Ardalan MR. Renal transplantation in patients with lupus nephritis: a single-center experience. Transplant Proc. 2008; 40(1): 143-4[DOI][PubMed]
  • 9. Ardalan MR, Shoja MM. Multiple myeloma presented as acute interstitial nephritis and rheumatoid arthritis-like polyarthritis. Am J Hematol. 2007; 82(4): 309-13[DOI][PubMed]
  • 10. Spitzer TR, Sykes M, Tolkoff-Rubin N, Kawai T, McAfee SL, Dey BR, et al. Long-term follow-up of recipients of combined human leukocyte antigen-matched bone marrow and kidney transplantation for multiple myeloma with end-stage renal disease. Transplantation. 2011; 91(6): 672-6[DOI][PubMed]
  • 11. Pham PT, Pham PC. Graft loss due to recurrent lupus nephritis in living-related kidney donation. Clin J Am Soc Nephrol. 2011; 6(9): 2296-9[DOI][PubMed]
  • 12. Fotouhi N, Ardalan M, Jabbarpour Bonyadi M, Abdolmohammadi R, Kamalifar A, Nasri H, et al. R229Q polymorphism of NPHS2 gene in patients with late-onset steroid-resistance nephrotic syndrome: a preliminary study. Iran J Kidney Dis. 2013; 7(5): 399-403[PubMed]
  • 13. Molnar MZ, Mehrotra R, Duong U, Bunnapradist S, Lukowsky LR, Krishnan M, et al. Dialysis modality and outcomes in kidney transplant recipients. Clin J Am Soc Nephrol. 2012; 7(2): 332-41[DOI][PubMed]
  • 14. Noshad H, Sadreddini S, Nezami N, Salekzamani Y, Ardalan MR. Comparison of outcome and quality of life: haemodialysis versus peritoneal dialysis patients. Singapore Med J. 2009; 50(2): 185-92[PubMed]
  • 15. Somi MH, Keivani H, Ardalan MR, Farhang S, Pouri AA. Hepatitis C virus genotypes in patients with end-stage renal disease in East Azerbaijan, Iran. Saudi J Kidney Dis Transpl. 2008; 19(3): 461-5[PubMed]
  • 16. Ardalan MR, Shoja MM, Ghabili K, Taheri S, Shakeri A, Etemadi J, et al. Fulminant acute pancreatitis in a patient with familial mediterranean fever on CAPD: what caused the pancreatitis? Perit Dial Int. 2009; 29(6): 676-8[PubMed]
  • 17. Ghafari A, Ardalan MR. Renal transplantation in elderly recipients: a single-center experience. Transplant Proc. 2008; 40(1): 238-9[DOI][PubMed]
  • 18. Ardalan MR, Tarzamani MK, Mortaazavi M, Bahloli A. Relation between resistive index and serum creatinine level in first month after renal transplantation. Transplant Proc. 2003; 35(7): 2628-9[PubMed]
  • 19. Ardalan MR, Tarzamani MK, Shoja MM. A correlation between direct and indirect Doppler ultrasonographic measures in transplant renal artery stenosis. Transplant Proc. 2007; 39(5): 1436-8[DOI][PubMed]
  • 20. Godwin JG, Ge X, Stephan K, Jurisch A, Tullius SG, Iacomini J. Identification of a microRNA signature of renal ischemia reperfusion injury. Proc Natl Acad Sci U S A. 2010; 107(32): 14339-44[DOI][PubMed]
  • 21. Zununi Vahed S, Nikasa P, Ardalan M. Klotho and renal fibrosis. Nephrourol Mon. 2013; 5(5): 946-8[DOI][PubMed]
  • 22. Zununi V. S. , Samadi N. Diagnosis of interstitial fibrosis and tubular atrophy in kidney allograft: implementation of microRNAs. Iran J Kidney Dis. 2014; 8: 4-12
  • 23. Archdeacon P, Chan M, Neuland C, Velidedeoglu E, Meyer J, Tracy L, et al. Summary of FDA antibody-mediated rejection workshop. Am J Transplant. 2011; 11(5): 896-906[DOI][PubMed]
  • 24. Kimball PM, Baker MA, Wagner MB, King A. Surveillance of alloantibodies after transplantation identifies the risk of chronic rejection. Kidney Int. 2011; 79(10): 1131-7[DOI][PubMed]
  • 25. Loupy A, Lefaucheur C, Vernerey D, Prugger C, Duong van Huyen JP, Mooney N, et al. Complement-binding anti-HLA antibodies and kidney-allograft survival. N Engl J Med. 2013; 369(13): 1215-26[DOI][PubMed]
  • 26. Burns JM, Cornell LD, Perry DK, Pollinger HS, Gloor JM, Kremers WK, et al. Alloantibody levels and acute humoral rejection early after positive crossmatch kidney transplantation. Am J Transplant. 2008; 8(12): 2684-94[DOI][PubMed]
  • 27. Riethmuller S, Ferrari-Lacraz S, Muller MK, Raptis DA, Hadaya K, Rusi B, et al. Donor-specific antibody levels and three generations of crossmatches to predict antibody-mediated rejection in kidney transplantation. Transplantation. 2010; 90(2): 160-7[PubMed]
  • 28. Alachkar N, Lonze BE, Zachary AA, Holechek MJ, Schillinger K, Cameron AM, et al. Infusion of high-dose intravenous immunoglobulin fails to lower the strength of human leukocyte antigen antibodies in highly sensitized patients. Transplantation. 2012; 94(2): 165-71[DOI][PubMed]
  • 29. Niederhaus SV, Muth B, Lorentzen DF, Wai P, Pirsch JD, Samaniego-Picota M, et al. Luminex-based desensitization protocols: the University of Wisconsin initial experience. Transplantation. 2011; 92(1): 12-7[DOI][PubMed]
  • 30. Djamali A, Muth BL, Ellis TM, Mohamed M, Fernandez LA, Miller KM, et al. Increased C4d in post-reperfusion biopsies and increased donor specific antibodies at one-week post transplant are risk factors for acute rejection in mild to moderately sensitized kidney transplant recipients. Kidney Int. 2013; 83(6): 1185-92[DOI][PubMed]
  • 31. Sampaio MS, Cho YW, Qazi Y, Bunnapradist S, Hutchinson IV, Shah T. Posttransplant malignancies in solid organ adult recipients: an analysis of the U.S. National Transplant Database. Transplantation. 2012; 94(10): 990-8[DOI][PubMed]
  • 32. Einollahi B, Rostami Z, Nourbala MH, Lessan-Pezeshki M, Simforoosh N, Nemati E, et al. Incidence of malignancy after living kidney transplantation: a multicenter study from iran. J Cancer. 2012; 3: 246-56[DOI][PubMed]
  • 33. Einollahi B, Lessan-Pezeshki M, Nourbala MH, Simforoosh N, Pourfarziani V, Nemati E, et al. Posttransplant lymphoproliferative disorders in kidney transplant recipients: an Iranian multicenter experience. Iran J Kidney Dis. 2008; 2(4): 227-33[PubMed]
  • 34. Einollahi B, Lessan-Pezeshki M, Nourbala MH, Simforoosh N, Pourfarziani V, Nemati E, et al. Kaposi's sarcoma following living donor kidney transplantation: review of 7,939 recipients. Int Urol Nephrol. 2009; 41(3): 679-85[DOI][PubMed]
  • 35. Sharif A. Should metformin be our antiglycemic agent of choice post-transplantation? Am J Transplant. 2011; 11(7): 1376-81[DOI][PubMed]
  • 36. Nasri H, Baradaran A, Ardalan MR, Mardani S, Momeni A, Rafieian-Kopaei M. Bright renoprotective properties of metformin: beyond blood glucose regulatory effects. Iran J Kidney Dis. 2013; 7(6): 423-8[PubMed]
  • 37. Ardalan M. Urinary tract infection associated with thrombotic microangiopathy. Nephrourol Mon. 2014; 6(1)[DOI][PubMed]
  • 38. Ardalan MR. Review of thrombotic microangiopathy (TMA), and post-renal transplant TMA. Saudi J Kidney Dis Transpl. 2006; 17(2): 235-44[PubMed]
  • 39. Ardalan MR, Shoja MM, Tubbs RS, Etemadi J, Esmaili H, Khosroshahi HT. Thrombotic microangiopathy in the early post-renal transplant period. Ren Fail. 2008; 30(2): 199-203[DOI][PubMed]
  • 40. Etemadi J, Mortazavi-Khosrowshahi M, Ardalan MR, Esmaili H, Javadrashid R, Shoja MM. Brown tumor of hyperparathyroidism masquerading as central giant cell granuloma in a renal transplant recipient: a case report. Transplant Proc. 2009; 41(7): 2920-2[DOI][PubMed]
  • 41. Nickeleit V, True K, Detwiler R, Kozlowski T, Singh H. Risk assessment for polyomavirus nephropathy using urine cytology and the detection of decoy cells: cheap and efficient. Transplantation. 2012; 94(7)-4[DOI][PubMed]
  • 42. Trydzenskaya H, Juerchott K, Lachmann N, Kotsch K, Kunert K, Weist B, et al. The genetic predisposition of natural killer cell to BK virus-associated nephropathy in renal transplant patients. Kidney Int. 2013; 84(2): 359-65[DOI][PubMed]
  • 43. Ardalan MR, Shoja MM, Tubbs RS, Ghabili K. Transplant renal artery stenosis associated with acute cytomegalovirus infection: resolution following ganciclovir administration. Ren Fail. 2009; 31(10): 982-4[DOI][PubMed]
  • 44. Ardalan M, Shoja MM. Cytomegalovirus-induced adrenal insufficiency in a renal transplant recipient. Transplant Proc. 2009; 41(7): 2915-6[DOI][PubMed]
  • 45. Ardalan M. Rare presentations of cytomegalovirus infection in renal allograft recipients. Nephrourol Mon. 2012; 4(2): 431-6[DOI][PubMed]
  • 46. Kotton CN. CMV: Prevention, Diagnosis and Therapy. Am J Transplant. 2013; 13 Suppl 3: 24-40[DOI][PubMed]
  • 47. Atabani SF, Smith C, Atkinson C, Aldridge RW, Rodriguez-Peralvarez M, Rolando N, et al. Cytomegalovirus replication kinetics in solid organ transplant recipients managed by preemptive therapy. Am J Transplant. 2012; 12(9): 2457-64[DOI][PubMed]
  • 48. Ardalan MR, Shoja MM, Tubbs RS, Jayne D. Parvovirus B19 microepidemic in renal transplant recipients with thrombotic microangiopathy and allograft vasculitis. Exp Clin Transplant. 2008; 6(2): 137-43[PubMed]
  • 49. Ardalan MR, Shoja MM, Tubbs RS, Esmaili H, Keyvani H. Postrenal transplant hemophagocytic lymphohistiocytosis and thrombotic microangiopathy associated with parvovirus b19 infection. Am J Transplant. 2008; 8(6): 1340-4[DOI][PubMed]
  • 50. Shoja MM, Ardalan MR, Etemadi J, Tubbs RS, Varshochi M. Renal allograft abscesses following transplant: case report and literature review. Exp Clin Transplant. 2007; 5(2): 720-3[PubMed]
  • 51. Ardalan MR, Ansarin K, Hejazi E, Nazemieh M, Safa J. Aspergillosis after renal transplantation. Saudi J Kidney Dis Transpl. 2005; 16(3): 330-3[PubMed]
  • 52. Ardalan MR, Shoja MM, Ghabili K. Concomitant pulmonary tuberculosis and tuberculous appendicitis in a recipient of a renal transplant: a case report. J Med Case Rep. 2011; 5: 191[DOI][PubMed]
  • 53. Ardalan M, Ghaffari A, Ghabili K, Shoja MM. Lepromatous leprosy in a kidney transplant recipient: a case report. Exp Clin Transplant. 2011; 9(3): 203-6[PubMed]
  • 54. Wadei H, Alangaden GJ, Sillix DH, El-Amm JM, Gruber SA, West MS, et al. West Nile virus encephalitis: an emerging disease in renal transplant recipients. Clin Transplant. 2004; 18(6): 753-8[DOI][PubMed]
  • 55. Ardalan MR, Tubbs RS, Chinikar S, Shoja MM. Crimean-Congo haemorrhagic fever presenting as thrombotic microangiopathy and acute renal failure. Nephrol Dial Transplant. 2006; 21(8): 2304-7[DOI][PubMed]
  • 56. Souza WM, Bello G, Amarilla AA, Alfonso HL, Aquino VH, Figueiredo LT. Phylogeography and evolutionary history of rodent-borne hantaviruses. Infect Genet Evol. 2014; 21: 198-204[DOI][PubMed]
  • 57. Ardalan MR, Ghabili K, Pourabbas R, Shoja MM. A causative link between periodontal disease and glomerulonephritis: a preliminary study. Ther Clin Risk Manag. 2011; 7: 93-8[DOI][PubMed]
  • 58. Ardalan MR, Shoja MM. Rapidly progressive glomerulonephritis in a patient with brucellosis. Nephrol Dial Transplant. 2006; 21(6): 1743-4[DOI][PubMed]
  • 59. Bonyadi M, Esmaeili M, Jalali H, Somi MH, Ghaffari A, Rafeey M, et al. MEFV mutations in Iranian Azeri Turkish patients with familial Mediterranean fever. Clin Genet. 2009; 76(5): 477-80[DOI][PubMed]
  • 60. Ardalan M. Massive proteinuria and acute glomerulonephritis picture in a patient with Familial Mediterranean fever and E148Q mutation. Iranian J Kid Dis. 1(1)
  • 61. Ardalan MR, Sadreddini S, Noshad H, Ebrahimi A, Molaeefard M, Somi MH, et al. Renal involvement in Behcet's disease. Saudi J Kidney Dis Transpl. 2009; 20(4): 618-22[PubMed]
  • 62. Ardalan MR, Shoja MM, Kiuru-Enari S. Amyloidosis-related nephrotic syndrome due to a G654A gelsolin mutation: the first report from the Middle East. Nephrol Dial Transplant. 2007; 22(1): 272-5[DOI][PubMed]
  • 63. Shoja MM, Ardalan MR, Tubbs RS, Kiuru-Enari S. Outcome of renal transplant in hereditary gelsolin amyloidosis. Am J Med Sci. 2009; 337(5): 370-2[DOI][PubMed]
  • 64. Ardalan M, Khodaie L, Nasri H. Herbs and Hazards; Admonishmen. Acid Neph J. 2014; 1(1)
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .
Readers' Comments